| I-30 Irina Baltcheva ggPMX: an open-source R package for pharmacometric model diagnostic plots Wednesday 09:50-11:15 |
| I-53 Astrid Broeker Parameter uncertainty in small datasets – evaluation approaches at their limit Wednesday 09:50-11:15 |
| II-07 Silvia Maria Lavezzi Pharmacokinetic Models for Drug and Metabolites Including First Pass Effects: A Priori and A Posteriori Identifiability Analysis Wednesday 15:10-16:40 |
| II-17 Giulia Lestini Handling dropouts in longitudinal observational studies – an illustration of a workflow from data preparation to model building and model diagnostics in Alzheimer’s disease Wednesday 15:10-16:40 |
| II-20 Dan Liu Investigating Impacts of Model Parameters Correlations in Global Sensitivity Analysis: Determining the most influential parameters of a Minimal PBPK Model of Midazolam Wednesday 15:10-16:40 |
| II-27 Inga Ludwig A Quantitative Approach to Assess Similarity of Adult and Pediatric Efficacy to Support Full or Partial Extrapolation in Pediatric Drug Development Wednesday 15:10-16:40 |
| II-78 Nikhil Pillai Single objective genetic algorithm based approach for optimal population pharmacokinetic/pharmacodynamics (PK/PD) model selection for tumor growth response Wednesday 15:10-16:40 |
| IV-11 Undine Falkenhagen Structural model selection: Is the chi-square distribution appropriate for likelihood ratio tests? Thursday 15:25-16:50 |
| IV-17 Chiara Fornari Importance of stability analysis when using non-linear semi-mechanistic models to describe drug-induced haematotoxicity Thursday 15:25-16:50 |
| IV-54 Ka Ho, Matthew Hui Evaluation of Parameter Estimation when Fitting a Mixture Model with Covariate Effects using NONMEM Thursday 15:25-16:50 |
